Geneva, May 4 -- International Clinical Trials Registry received information related to the study (NCT07549490) titled 'Human Experimental Models of Pain (HEMP)' on April 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: National Center for Complementary and Integrative Health (NCCIH)
Condition:
Acute Pain
Intervention:
Drug: Placebo
Drug: Naproxen
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 15, 2026
Target Sample Size: 25
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT...